AIMBE Announces 2020 College of Fellows Inductees

drs b, d, and w

The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of these McGowan Institute for Regenerative Medicine affiliated faculty members to its College of Fellows:

Christopher Bettinger, PhD: For outstanding contributions to integrating biomimetic materials and flexible electronics into biomedical devices and implants.
Kris Dahl, PhD: For providing foundational structure-function information about the cell nucleus that changes how that organelle is viewed in mechanotransduction.
Douglas Weber, PhD: For outstanding contributions to neurorehabilitation engineering, translational neuroscience, and leadership in the field of neural engineering.

Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to a medical and biological engineer. The College of Fellows is comprised of the top two percent of medical and biological engineers. College membership honors those who have made outstanding contributions to “engineering and medicine research, practice, or education” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering, or developing/implementing innovative approaches to bioengineering education.”

While most AIMBE Fellows hail from the United States, the College of Fellows has inducted Fellows representing 34 countries. AIMBE Fellows are employed in academia, industry, clinical practice and government.

AIMBE Fellows are among the most distinguished medical and biological engineers including 3 Nobel Prize laureates, 18 Fellows having received the Presidential Medal of Science and/or Technology and Innovation, and 173 also inducted to the National Academy of Engineering, 84 inducted to the National Academy of Medicine and 37 inducted to the National Academy of Sciences.

AIMBE is the authoritative voice and advocate for the value of medical and biological engineering to society. AIMBE’s mission is to recognize excellence, advance the public understanding, and accelerate medical and biological innovation. No other organization can bring together academic, industry, government, and scientific societies to form a highly influential community advancing medical and biological engineering. AIMBE’s mission drives advocacy initiatives into action on Capitol Hill and beyond.

Congratulations, all!